High Incidence of False-Positive Results in Patients with Acute Infections Other than COVID-19 by the Liaison SARS-CoV-2 Commercial Chemiluminescent Microparticle Immunoassay for Detection of IgG Anti-SARS-CoV-2 Antibodies

Ítems similars

• Clinical application of Chemiluminescence Microparticle Immunoassay for SARS-CoV-2 infection diagnosis
  per: Liu, Wanbing, et al.
  Publicat: (2020)
• Caution in interpretation of SARS-CoV-2 quantification based on RT-PCR cycle threshold value
  per: Schnuriger, Aurélie, et al.
  Publicat: (2021)
• Serological chemiluminescence immunoassay for the diagnosis of SARS‐CoV‐2 infection
  per: Lijia, Shao, et al.
  Publicat: (2020)
• Performance of the LIAISON(®) SARS-CoV-2 Antigen Assay vs. SARS-CoV-2-RT-PCR
  per: Fiedler, Melanie, et al.
  Publicat: (2021)
• Correlation of SARS-CoV-2 neutralizing antibodies to an automated chemiluminescent serological immunoassay
  per: Grenache, David G, et al.
  Publicat: (2020)